| COMPOSITION: | Each gastro-resistant bilayered tablet contains enteric coated Rabeprazole Sodium 20 mg & Levosulpiride (in sustained release form) SR 75 mg (Tablet in Capsule formulation) |
| FORMULATION: | CAPSULES |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Rebozen-SL Capsules contains Rabeprazole, a PPI that inhibits acid & Levosulpiride, an anti-psychotic & Prokinetic drug that increases the movement in GI tract. It is indicated in the treatment of gastroesophageal reflux disease (GERD) in Patients who do not respond to monotherapy with PPI's. It is also indicated in Zollinger-Ellison syndrome, gastric and duodenal ulcers. |
| SIDE EFFECTS: | Common side effects are Headache, nausea, vomiting, constipation, diarrhea, gas and sore throat. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
